COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > SO OATS GUESS WHO IS UP FOR THE NEW BOARD

<< Previous

Bullboard Posts

Next >>

Comment by Ciaoon Jun 29, 2024 12:46pm

87 Views

Post# 36112104

RE:SO OATS GUESS WHO IS UP FOR THE NEW BOARD

Shareholders should vote NO to the resolution for changing the company's name. New investors need to be warned of the historical performance and mismanagement of the company. I can assure you that once the name change occurs, there will be an equity raise.

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project